Publication|Articles|October 4, 2024
- Pharmaceutical Commerce - October 2024
- Volume 19
- Issue 5
Pharmaceutical Commerce - October 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce October 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
Strengthening the Chainabout 1 year ago
A Sense of Urgencyabout 1 year ago
Conference Connect: The Twists and Turns in Pharma Traceabilityabout 1 year ago
Tapping the Value of Conscientious Stewardshipabout 1 year ago
Specialty Pharmacy: The Trends Shaping Best Practicesabout 1 year ago
Three Key Pharmaceutical Logistics Challenges to Monitorabout 1 year ago
Key Elements for Success in Pharma M&A Integrationabout 1 year ago
The Latest Surrounding Rising Medicare Part D Premiumsabout 1 year ago
Reflections on IRA Drug Pricing NegotiationsNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cambrex Commits $120 Million to Grow US API Manufacturing
2
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
3
Direct-to-patient: pharma’s next power move
4
